MAPT and Alzheimer disease: According to this trial pathway amyloid-tau-mitochondrial integrative hypothesis, it can be assumed that the interaction of risk factors and biomarkers and their mutual potentiation are more decisive for the development of AD than a primary role exerted by any of them individually.